Journal article
Lung Cancer Screening
The Medical clinics of North America, Vol.101(4), pp.769-785
07/2017
DOI: 10.1016/j.mcna.2017.03.008
PMID: 28577626
Abstract
Lung cancer is the leading cause of cancer death in the United States. More than 80% of these deaths are attributed to tobacco use, and primary prevention can effectively reduce the cancer burden. The National Lung Screening Trial showed that low-dose computed tomography (LDCT) screening could reduce lung cancer mortality in high-risk patients by 20% compared with chest radiography. The US Preventive Services Task Force recommends annual LDCT screening for persons aged 55 to 80 years with a 30-pack-year smoking history, either currently smoking or having quit within 15 years.
Details
- Title: Subtitle
- Lung Cancer Screening
- Creators
- Richard M Hoffman - Department of Medicine, University of Iowa Carver College of Medicine, 200 Hawkins Drive SE 618 GH, Iowa City, IA 52242, USARolando Sanchez - Department of Medicine, University of Iowa Carver College of Medicine, 200 Hawkins Drive C325 GH, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- The Medical clinics of North America, Vol.101(4), pp.769-785
- DOI
- 10.1016/j.mcna.2017.03.008
- PMID
- 28577626
- NLM abbreviation
- Med Clin North Am
- ISSN
- 0025-7125
- eISSN
- 1557-9859
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 07/2017
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Epidemiology; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984094371002771
Metrics
29 Record Views